within Pharmacolibrary.Drugs.ATC.A;

model A06AD04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1.0,
    Cl             = 4.28 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 4000 / 1000000,
    adminCount     = 1,
    Vd             = 0.01326,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium sulfate is an inorganic salt used in medicine for a variety of indications. It is primarily used intravenously for the prevention and treatment of seizures in pre-eclampsia and eclampsia, as well as in the management of hypomagnesemia and torsades de pointes. It is also administered orally as a laxative. Magnesium sulfate is an approved and widely used medication in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult pregnant women with pre-eclampsia, following intravenous administration. Population pharmacokinetic study.</p><h4>References</h4><ol><li><p>Lu, JF, &amp; Nightingale, CH (2000). Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. <i>Clinical pharmacokinetics</i> 38(4) 305–314. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200038040-00002&quot;>10.2165/00003088-200038040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10803454/&quot;>https://pubmed.ncbi.nlm.nih.gov/10803454</a></p></li><li><p>Rower, JE, et al., &amp; Finkelstein, Y (2025). Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. <i>Journal of clinical pharmacology</i> 65(6) 665–674. DOI:<a href=&quot;https://doi.org/10.1002/jcph.6179&quot;>10.1002/jcph.6179</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39775569/&quot;>https://pubmed.ncbi.nlm.nih.gov/39775569</a></p></li><li><p>Brookfield, K, et al., &amp; Carvalho, B (2021). Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. <i>AJOG global reports</i> 1(4) 100018–None. DOI:<a href=&quot;https://doi.org/10.1016/j.xagr.2021.100018&quot;>10.1016/j.xagr.2021.100018</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36277458/&quot;>https://pubmed.ncbi.nlm.nih.gov/36277458</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A06AD04;
